Pinned Tweet
EU-SolidAct is part of the EU-RESPONSE project who has received funding from the European Union’s Horizon 2020 Research and Innovation Program under grant agreement No 101015736. @EUScienceInnov
Results of the Bari-SolidAct clinical trial, conducted in 14 European countries, have been published in Critical Care.
eu-response.eu/eu-solidact-p…
pubmed.ncbi.nlm.nih.gov/3662…
DMC/DSMB members do very valuable and mostly unappreciated work in RCTs. Thank you very much drs. @stefano_vella, Du, Medaglini, Jacobs, vd Werf, Medaglini, @pocock_stuart, @phaikyeong, Barnes, Yeni and Collier for excellent work in our DMC!
1
3
Replying to @BGenBio
@BGenBio and @Oslounivsykehus announce the AXL Inhibitor Bemcentinib will be Studied in the EU Funded @EU_SolidAct trial in Hospitalised COVID-19 Patients
eu-response.eu/bergenbio-and…
@EUScienceInnov/@Inserm/@ECRIN_ERIC
Now Austria and and the Medical University of Innsbruck has included their first patient in the EU-SolidAct trial on Baricitinib treatment
@EUScienceInnov/@ECRIN_ERIC/@Oslounivsykehus/@Inserm
Happy to inform that we have now reached 200 randomised patients! We have opened 45 sites in 10 countries, with more to follow.
@EUScienceInnov
/
@ECRIN_ERIC
/
@Oslounivsykehus
/
@Inserm
Happy to inform that Belgium and Luxembourg have now included their first patients, making them the 6th and 7th country with more to come!
2
Happy to inform that we have now reached 100 randomised patients! We are recruiting in 33 sites in 5 countries, with more to follow.
@EUScienceInnov/@ECRIN_ERIC/@Oslounivsykehus/
@Inserm
Baricitinib/placebo has arrived @LovisenbergSH! @simenws and colleagues are ready to include their first patient in the Trial as the eight European site.
Happy to inform that the two first patients are included, the first at the world's northernmost university hospital @UNN_HF with PI A Kildal and the second in @SykehusVestfold with PI @dr_asgeir!
@EUScienceInnov / @ECRIN_ERIC / @Oslounivsykehus / @Inserm



